space coast

Talcum Powder Lawyers For Ovarian Cancer Lawsuits

Written by

Did You Use Talc Baby Powder?

Have You Been Diagnosed With Ovarian Cancer?

Talcum powder lawyers are filing Talcum Powder lawsuits for women who have gotten ovarian cancer from Talcum Powder.

Think talcum powder and many of us picture chortling babies and smiling mothers changing diapers. Nothing seems more safe and wholesome. And many women use talc products daily, as well, for feminine hygiene and after showering.

Do you remember this famous phrase from Johnson & Johnson s Shower to Shower  ads?  Just a sprinkle a day helps keep odor away. Well that sprinkle is now resulting in  women  filing  lawsuits against Johnson & Johnson claiming  that talc in this and other products led to them developing  ovarian cancer. They claim that the they  should have been warned.

Johnson s baby powder was one of the company s household name  products.  It has been sold for more than a 100 years. Now they say it can cause ovarian cancer?  A recent lawsuit awarded $72 million to a woman whose ovarian cancer could be scientifically linked to use of Talc.

But, you say,  I have been using this product for years. Since I was a  teenager or younger and they knew and did not tell us? Yes, in the  last few decades, studies have suggested a possible link between talc and ovarian cancer.

These studies go back, he says, to a British study in 1971. Researchers reported that microscopic analysis of 13 ovarian tumors found talc particles in 10 of them. Several other studies followed in the early 1980s in the United States and Europe and suggested that women who use talc feminine hygiene products may have up to a 35% higher risk of ovarian cancer than women who don’t those products.

The Johnson and Johnson website proclaims  Few ingredients have demonstrated the same performance, mildness and safety profile as cosmetic talc, which has been used for over 100 years by millions of people around the world. It goes on to note that talc is used in a range of other consumer products such as toothpaste, chewing gum, and aspirin.

If you think you have gotten ovarian cancer from Talcum powder contact us today to speak to a Talcum Powder lawyer

Bard IVC Filters Get National Attention | IVC Lawyers Filing Lawsuits

Written by

Bard IVC Lawsuits Are Being Filed By IVC Filter Lawyers

Bard IVC Filter Injury Lawsuit News

The Bard IVC filter lawsuits came to national awareness with the NBC Nightly News segment on IVC filter complications.

A National broadcast has raised public awareness of current lawsuits filed by IVC filter lawyers against Bard. Lawsuits have been filed for patients whi have had a Bard IVC filter break or fail. These IVC lawsuits are consolidated as multidistrict litigation, MDL 2641 Bard IVC Filters Products Liability Litigation.

The Bard IVC lawyers of our Bard Injury Lawyer Network are pleased to see that there is now an awareness as these filters are primarily implanted in an older population. Attorneys representing families in IVC filter lawsuits are now accepting lawsuits for inclusion in the Bard IVC Filter MDL.

The Bard IVC filters are breaking, fracturing, and moving inside the body, causing damage to the heart and lungs and resulting in stroke and death according to adverse incident reports.

Our National Bard IVC Filter Helpline is ready to assist families, victims and caregivers. The National Bard IVC filter lawyers are accepting claims from victims, and their family members for injuries and deaths from the Bard IVC filter.

The vena cava filters are implanted in the veins of patients to catch blood clots before they reach the lungs. The filters have complications including vein and organ perforation, migration and breakage. This can result in injury or even death of patients.


Xarelto Extensive Bleeding Lawsuits Increase

Written by

Xarelto is a medication which thins the blood. Xarelto has been shown to cause excessive bleeding resulting in serious injury and sometimes death. There is no way to stop the bleeding. Xarelto lawyers are filing lawsuits against the manufacturer for lack of warnings regarding their medication.

In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. At the time, about 50 product liability lawsuits were pending in the court. That number has now increased to about 400.

Not long after the Xarelto MDL was established, Philadelphia consolidated all state Xarelto lawsuits into a mass tort in the Philadelphia County Court of Common Pleas. What started as about 70 cases has now increased to about 200.

Defendants Resisted Formation of Mass Tort

Plaintiffs involved in Xarelto lawsuits claim that Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals—manufacturers of the drug—should be held liable for damages associated with serious Xarelto side effects, including severe gastrointestinal bleeding and sometimes death.

The defendants initially resisted consolidating cases in Philadelphia, arguing that New Jersey would be a better location, since that’s where the company headquarters are located. They added that most plaintiffs also lived in other states, so it didn’t make sense to bring all cases to Pennsylvania.

The cases all do not involve common issues of fact, either, the defendants argued, since Xarelto is approved for multiple purposes. These include the prevention of blood clots after hip and knee replacement surgery, and the reduction of stroke risk in patients with non-valvular atrial fibrillation.

The court disagreed, stating the cases did share common issues of fact, that the defendants had strong ties to Pennsylvania, and that the Philadelphia court was an appropriate forum for the mass tort.

The companies expressed their intentions to defend against the claims brought in litigation, maintaining that Xarelto has a favorable benefit-risk profile.

Drug Makers Failed to Warn About Serious Xarelto Side Effects

The FDA approved Xarelto in 2011. Manufacturers immediately marketed it as a more convenient option to warfarin, the leading anti-coagulant for decades, because it came in a once-daily dose and required no dietary restrictions.

Within just a year, however, reports of excessive bleeding began coming in, numbering more than 1,000 by June 30, 2012—at least 65 of those involving the death of the patient. By the end of that year, more than 151 people had died in events related to Xarelto.

Plaintiffs filed lawsuits to recover damages, claiming that the drug makers had failed to provide proper warnings on the labels. Patients were left in the dark, for instance, on the fact that there was no readily available antidote to Xarelto bleeding. While all blood thinners carry some risk of bleeding, patients taking warfarin can have that bleeding stopped with vitamin K injections. There is no such solution for patients on Xarelto, making bleeding events much more serious and potentially deadly.

State and Federal Courts to Coordinate Pre-Trial Proceedings

Both parties plan to coordinate the mass tort with the Xarelto MDL. In a recent case management conference, for instance, held in April 2015, the MDL court noted that five days before each future status conference, the defendants are to identify and share any Xarelto lawsuits pending in state courts, to facilitate coordination.

If you or a loved one has been injured by Xarelto contact us for an Xarelto attorney.

Cystocele and Rectocele Mesh Repair, FDA Warnings

Written by

Risks with Cystocele and Rectocele Mesh Repair , FDA Warnings, Vaginal mesh lawyers

In July 2011, the FDA released a safety communication warning healthcare providers of the serious risks associated with surgical mesh used to repair pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Specifically, the FDA stated that complications were not rare, and that surgery with the mesh may be no better than traditional surgery options that don’t use mesh.

Public Citizen and Vaginal mesh

In October 25, 2011, a consumer advocacy group called Public Citizen submitted an appeal to the FDA that all non-absorbable vaginal mesh be recalled. They stressed that there is a need for these non-absorbable vaginal meshes to be removed from the market since it’s benefits over other non-mesh procedures used to repair POP and SUI were unseen, and patients who received them developed fatal reactions. The group also recommends that all non-absorbable vaginal mesh be tested appropriately for safety and effectiveness before the FDA approves its availability in the market.

FDA 510 (K) Process

Manufacturers needed only to show they were similar to devices already on the market to gain approval through the FDA’s 510(k) approval process. The remaining eight recalled devices didn’t have to go through any kind of FDA review. Of the 113 recalls, 35 were for cardiovascular devices, including automated external defibrillators, or AEDs, and only 12 of them had been required to undergo patient testing.

POP repair surgeries may include cystocele and rectocele. Unfortunately, complications have been found with both.
Types of POP Repair Include Cystocele and Rectocele.The sling procedure, or suburethral sling procedure, refers to a particular kind of surgery using ancillary material to aid in closure of the urethral sphincter function of the bladder. It is performed as a treatment of severe urinary incontinence. The sling procedure, also known as the suburethral fascial sling or the pubovaginal sling, has many forms due to advances in the types of material used for the sling. Some popular types of sling material are Teflon (polytetrafluoroethylene), Gore-Tex ® , and rectus fascia (fibrous tissue of the rectum).

Cystocele and rectocele repair

  • Cystocele—bladder prolapse
  • Rectocele—rectal prolapse (end of the large intestine, or rectum)
  • Uterine prolapse
  • Vaginal prolapse
  • Enterocele—herniated small bowel

Mesh was initially incorporated into POP surgical repair because it offered more support to the affected organ and helped shore up surrounding muscles and tissues. Since the risk for recurrence of prolapse is high in women who have cystocele surgery and rectocele surgery, the hope was that surgical mesh would help sustain the repair. The FDA received many reports, however, or cystocele mesh complications and rectocele mesh complications.

Mesh complications

  • erosion of mesh
  • serious infection
  • recurrence of pop / sui
  • perforation
  • pain
  • corrective surgeries
  • injury to other organs
  • vaginal scarring
  • urinary problems
  • hardening of mesh

Cystocele Mesh Complications and Rectocele Mesh Complications

During cystocele surgery, transvaginal mesh is inserted through the vagina to help act as a barrier and to hold the bladder in place. The mesh is also intended to help stop related problems like incontinence.

A rectocele occurs when the thin wall of tissue separating the rectum from the vagina weakens, allowing the front of the rectum to bulge into the vagina. During rectocele surgery, excess stretched tissue is removed through the vagina, and a mesh patch may be used to support and strengthen the wall. (Surgery may also proceed from the abdomen, anus, or perineum.)

Though surgical mesh does seem to provide better support for pelvic organs, cystocele mesh complications and rectocele mesh complications made the improvement a moot point. The FDA, in its 2011 warning, mentioned that it had received nearly 3,000 reports of vaginal mesh complications between 2008 and 2010, with the most common being mesh erosion through the vagina. Mesh erosion can require multiple surgeries to repair and may be extremely debilitating.

Other cystocele mesh complications and rectocele mesh complications included pain, infection, bleeding, pain during sex, organ perforation, urinary problems, recurrent prolapse, vaginal scarring/shrinkage, and neuro-muscular problems. Many required additional surgical treatment and hospitalization.
Cystocele Surgery and Rectocele Surgery

Cystocele, urethrocele, enterocele, and rectocele are particularly likely to occur together. Urethrocele is virtually always accompanied by cystocele (cystourethrocele). Cystocele and cystourethrocele commonly develop when the pubocervical vesical fascia is weakened. Enterocele usually occurs after a hysterectomy. Weakness in the pubocervical fascia and rectovaginal fascia allows the apex of the vagina, which contains the peritoneum and small bowel, to descend. Rectocele results from disruption of the levator ani muscles.

Severity of these disorders can be graded based on level of protrusion:

  • 1st degree: To the upper vagina
  • 2nd degree: To the introitus
  • 3rd degree: External to the introitus

If you have been injured due to a vaginal mesh from any of the manufactuirers listed below contact Vaginal mesh Helpline 1 877 522-2123

Manufacturers

Johnson & Johnson

  • Ethicon TVT
  • Gynecare Prolift
  • Gynecare Prosima
  • Gynecare TVT
  • Gynemesh PS

C.R. Bard

  • Avaulta PlusT BioSynthetic Support
  • Avaulta SoloT Synthetic Support
  • Faslata Allograft
  • PelvitexT Polypropylene Mesh
  • Pelvicol Tissue
  • PelviSoft Biomesh

Boston Scientific

  • AdvantageT Sling System
  • Prefyx Mid UT Mesh Sling System
  • Prefyx PPST System
  • Obtryx Curved Single
  • ObtryxMesh Sling
  • Arise
  • Pinnacle
  • Solyx
  • Lynx

American Medical Systems

  • SPARC
  • BioArc
  • MiniArc
  • Apogee
  • Elevate
  • Monarc
  • In-Fast
  • Perigree

vaginalmeshhelpline.com